DurAVR™ selected as Best Innovation in Aortic Valve Therapy at PCR Valves eCourse 2020
Share
DurAVR™ FIH was selected from PCRValves eCourse 2020 as Best Innovation. Prof Bart Meuris showed that the DurAVR™ design aims at reducing leaflet stress by increasing coaptation area; having the potential to deliver a functional cure to severe aortic stenosis patients.
This website may use cookies to analyze your traffic on this site. Anonymised data from the site may be supplied to social media, advertising and analytics partners who may combine it with other information that you’ve provided or that they’ve collected from your use of their services
